An analysis of disease - gene relationship from Medline abstracts by DigSee Jeongkyun Kim 1 , Jung - jae Kim 2 , and Hyunju Lee 1 , * 1 Gwangju institute of science and technology , School of Electrical Engineering and Computer Science , Gwangju , 61005 , Korea 2 1 Fusionopolis Way , # 21 ‚Äì 01 Connexis ( South Tower ) , Singapore 138632 * hyunjulee @ gist . ac . kr Supporting Information Supplementary Note . Re - evaluation of text mining tools and detailed ranking method of DigSee Supplementary Figure 1 . Overlap ratio of disease - related genes between OMIM , GWAS , and DigSee with top ranked genes . Supplementary Figure 2 . Comparison results of DigSee and other text mining tools with OMIM and GWAS . Supplementary Figure 3 . Separation coefficients and gene ontology ( GO ) term similarities between genes using top - ranked genes . Supplementary Table 1 . Statistics of evidence sentences , disease - related genes , and abstracts for general disease categories . Supplementary Table 2 . Commonly identified disease - related genes from Online Mendelian Inheritance in Man ( OMIM ) , Genome - Wise Association Studies ( GWAS ) , and DigSee . Supplementary Table 3 . Lists of disease - related genes from AlzGene , the Text - mined Hypertension , Obesity and Diabetes ( T - HOD ) database , DrugBank , and DigSee . Supplementary Table 4 . Manual validation of genes related to Alzheimer‚Äôs disease and hypertension in DigSee . Supplementary Table 5 . Top 100 genes related to Alzheimer‚Äôs disease in DigSee and validation of these genes . Supplementary Table 6 . Analysis of genes related to Alzheimer‚Äôs disease that were not identified by DigSee but found in AlzGene . Supplementary Table 7 . Analysis of genes related to hypertension that were not identified by DigSee but found in T - HOD . Supplementary Table 8 . Overlap coefficients , jaccard indices , and separation coefficients between disease pairs using all disease - related genes in DigSee . Supplementary Tables 9 - 11 . Overlap coefficients , jaccard indices , separation coefficients , and GO similarities between disease pairs using the top 100 , 200 , or 300 disease - related genes in DigSee . Supplementary Table 12 . Ratio of mutations and gene expressions among biological events for each disease type . Supplementary Tables 13 - 16 . Gold standard evidence sentences for Alzheimer‚Äôs disease , hypertension and extended biological events . Supplementary Table 17 . Performances of the Bayesian model for ranking evidence sentences for EPI biological events and mutation . Supplementary Table 18 . Performances of the Bayesian model for ranking evidence sentences for Alzheimer‚Äôs disease and hypertension . Supplementary Note Re - evaluation of text mining tools used in DigSee DigSee used several state - of - the - art text mining tools to identify disease - gene relations . To confirm if the performance is consistent with the Medline abstracts relevant to our study , we re - evaluated TEES and the other text mining tools against 100 sample Medline abstracts of our experiments and found similar results as follows : A . Turku event extraction system DigSee utilizes the Turku event extraction system ( TEES ) 1 to locate biological events in Medline abstracts . It was reported to achieve a precision of 53 . 98 % , a recall of 52 . 69 % , and an F measure of 53 . 33 % at the EPI task in BioNLP - ST 2011 . 2 We tested TEES with randomly selected 100 Medline abstracts . In the sample abstracts , TEES extracted total 1177 event relations , 55 . 14 % of which were identified correct ( 679 relations ) in both named - entity recognition ( NER ) and event relation . Among the incorrect relations , 83 relations were attributed to the errors of ABNER . B . ABNER ABNER , 3 the NER tool for identifying gene and protein mentions , shows a precision of 77 . 93 % in sample Medline abstracts . The accuracy of ABNER was previously known to achieve an F - measure of 69 . 9 % in the previous study . 3 We also compared BANNER 4 and Gimli 5 with ABNER in the DigSee pipeline . In the validation results , from the 100 abstracts , ABNER and BANNER extracted 1 , 278 and 1 , 265 gene names with similar accuracies ( ABNER : a precision of 77 . 93 % and BANNER : a precision of 76 . 44 % ) . Although the precision of Gimli was higher as 82 . 57 % than the other two tools , it identifies the smaller number of genes names ( 1 , 033 ) . Based on these empirical results , we used ABNER as the NER tool . C . DNorm We use DNorm 6 for extracting disease mentions and normalizing diverse disease names into standard terms . In the results of sample Medline abstracts that randomly selected 100 abstracts , DNorm recognized 778 disease mentions , 76 . 34 % of which were identified correct in both NER and normalization . DNorm was known to achieve an F - measure of 80 . 9 % against a test set of the NCBI disease corpus in the previous study . 6 D . tmVar For locating mutation event , DigSee utilizes tmVar . 7 tmVar was reported to achieve an F - measure of 91 . 39 % ( a precision of 91 . 38 % and a recall of 91 . 40 % ) . tmVar achieved a precision of 99 . 58 % from randomly selected 100 sample Medline abstracts . In the sample abstracts , tmVar recognized total 726 mutation mentions . E . Moara Moara 8 is a flexible and trainable text mining system for gene / protein tagger and normalization . The system has been trained for several model organisms and corpora , moreover it can be expanded to support new organisms and documents . DigSee utilizes the Moara to normalize recognized gene mentions with human model , but not used to recognize gene and protein mentions . Moara achieved a precision of 55 . 00 % , a recall of 83 . 31 % , and an F - measure of 66 . 26 % in the previous study . 8 In the randomly selected 100 Medline abstracts , Moara achieved a precision of 75 . 10 % in the normalization step . A ranking method for evidence sentences To distinguish positive sentences supporting the triplet relationship of gene , disease , and biological event from negative sentences that do not describe the relationship , we previously developed a Bayesian model based on ten linguistically motivated features were constructed using the feature selection sentences 9 such as event and edge scores , gene - event distance , event - regulation distance , and event - disease distance , event depth , cancer keywords count , hallmark keywords count , negative score , and agent . These features were obtained from ABNER 3 and Turku event extraction system 1 , dependency parse trees generated by Stanford parser , hand - crafted disease - related terms , and terms related to negative sentences . Developed Bayesian classifier with the features was modeled to identify positive evidence sentences from negative sentences . By assigning the same prior to positive and negative evidence sentences , we calculated a likelihood ratio of features , L ( features ) = ùëùùëù ( features | positive ) ùëùùëù ( features | negative ) Basically , na√Øve Bayesian classifier assumes conditional independence among features . However , we empirically chose two types of dependencies , a dependency between cancer keyword and event - cancer distance and a dependency between agent and hallmark keywords count , after analyzing the feature selection data set . Therefore , the likelihood ratio can be rewritten as follows : ùêøùêø ( features ) = ÔøΩ ùëùùëù ( features ùëñùëñ | positive ) ùëùùëù ( features ùëñùëñ | negative ) ‚ãÖ ùëùùëù ( cancer keywords count | positive , event - cancer distance ) ùëùùëù ( cancer keywords count | negative , event - cancer distance ) features ùëñùëñ ‚ãÖ ùëùùëù ( agent | positive , hallmark keywords count ) ùëùùëù ( agent | negative , hallmark keywords count ) Among the features , two features of ‚Äúcancer keywords count‚Äù and ‚Äúhallmark keywords count‚Äù were based on hand - crafted disease - related terms that means disease - dependent features . To adopt two features for all diseases , we develop a method of collecting disease - related terms using Word2Vec . 10 Word2Vec computes continuous vector representations of words based on neural networks , where the word vectors can be used for certain inference . At first , we computed the vectors of words using all sentences in disease - related Medline abstracts . The ten most similar words of each disease name in the vector space were selected as disease keywords . In addition , we identified hallmarks of a given disease ( e . g . , hypertension ) by contrasting them with known pairs of cancers and their hallmarks ( e . g . , proliferation ) . In particular , we used vector operations such as vector ( ‚Äúcancer‚Äù ) ‚àí vector ( ‚Äúproliferation‚Äù ) + vector ( ‚Äúhypertension " ) to predict terms related to the given disease . For example , term ‚Äúblood pressure‚Äù was found to be the top hallmark of hypertension using example vector operation . Additional methods for ranking disease - related gene ranking In addition to the five measures introduced in ‚ÄúImproving disease - related gene ranking‚Äù in the Method section , we augmented the fourth and fifth measures with biological events in order to see whether particular biological events might affect gene ranking and generated four additional ranking . First , for each disease , the ratios of biological events were calculated , and the summation and the average of normalized scores were multiplied by the event ratio ( 6 th and 7 th rankings ) . Second , for each gene , event ratios were calculated and the summation and the average of normalized scores were multiplied by the event ratio of genes ( 8 th and 9 th rankings ) ( Supplementary Figure 1 ) . References 1 . Bj¬®orne , J . & Salakoski , T . Generalizing biomedical event extraction . In Proceedings of the BioNLP Shared Task 2011 Workshop , 183 ‚Äì 191 ( 2011 ) . 2 . Ohta , T . , Pyysalo , S . & Tsujii , J . Overview of the epigenetics and post - translational modifications ( epi ) task of bionlp shared task 2011 . In Proceedings of the BioNLP Shared Task 2011 Workshop , 16 ‚Äì 25 ( 2011 ) . 3 . Settles , B . Abner : an open source tool for automatically tagging genes , proteins and other entity names in text . Bioinformatics 21 , 3191 ‚Äì 3192 ( 2005 ) . 4 . Leaman , R . , Gonzalez , G . et al . Banner : an executable survey of advances in biomedical named entity recognition . In Pacific symposium on biocomputing , vol . 13 , 652 ‚Äì 663 ( 2008 ) . 5 . Campos , D . , Matos , S . & Oliveira , J . L . Gimli : open source and high - performance biomedical name recognition . BMC Bioinformatics 14 , 54 ( 2013 ) . 6 . Leaman , R . , Islamaj DoÀògan , R . & Lu , Z . Dnorm : disease name normalization with pairwise learning to rank . Bioinformatics 29 , 2909 ‚Äì 2917 ( 2013 ) . 7 . Wei , C . - H . , Harris , B . R . , Kao , H . - Y . & Lu , Z . tmvar : a text mining approach for extracting sequence variants in biomedical literature . Bioinformatics 29 , 1433 ‚Äì 1439 ( 2013 ) . 8 . Neves , M . L . , Carazo , J . - M . & Pascual - Montano , A . Moara : a java library for extracting and normalizing gene and protein mentions . BMC Bioinformatics 11 , 157 ( 2010 ) . 9 . Kim , J . et al . Digsee : disease gene search engine with evidence sentences ( version cancer ) . Nucleic Acids Research 41 , W510 ‚Äì W517 ( 2013 ) . 10 . Mikolov , T . , Chen , K . , Corrado , G . & Dean , J . Efficient estimation of word representations in vector space . arXiv : 1301 . 3781 ( 2013 ) . # of abstracts # of evidence sentences Score of evidence sentences Summation of nor malized score Average of normalized score Multiply event ratio of disease Multiply event ratio of gene Summation of normalized score Average of normalized score Summation of normalized score Average of normalized score Top 100 genes 17 % 18 % 11 % 16 % 2 % 8 % 8 % 16 % 2 % Top 200 genes 12 % 13 % 8 % 11 % 3 % 7 % 7 % 11 % 3 % Top 300 genes 10 % 10 % 7 % 9 % 3 % 6 % 6 % 9 % 3 % 0 % 5 % 10 % 15 % 20 % Top 100 genes per disease Top 200 genes per disease Top 300 genes per disease O v e r l a p r a ti o w it h O M I M a nd G W A S # of abstracts # of evidence sentences Score of evidence sentences Summation of normalized score Average of normalized score Summation of normalized score multiply event ratio of disease Average of normalized score multiply event ratio of disease Summation of normalized score multiply event ratio of gene Average of normalized score multiply event ratio of gene 0 100 , 000 200 , 000 300 , 000 400 , 000 500 , 000 600 , 000 0 % 5 % 10 % 15 % 20 % No threshold Threshold 0 . 2 Threshold 0 . 4 Threshold 0 . 6 Threshold 0 . 8 O v e r l a p r a ti o w it h O M I M a nd G W A S Number of used evidence sentences Top 100 genes per disease Top 200 genes per disease Top 300 genes per disease ( A ) ( B ) ( C ) Supplementary Figure 1 PolySearch2 DISEASES DisGeNet DigSee OMIM GWAS OMIM GWAS OMIM GWAS OMIM GWAS 1 . 00 2 0 17 4 23 4 26 1 1 . 00 ~ 0 . 75 2 0 57 1 25 16 165 0 0 . 75 ~ 0 . 50 13 2 64 11 38 18 76 7 0 . 50 ~ 0 . 25 40 5 29 70 48 21 14 114 0 . 25 ~ 0 . 10 50 29 8 39 40 38 2 74 0 . 10 ~ 0 . 00 89 76 9 17 38 46 0 19 0 89 119 6 20 47 66 2 17 Not searched 4 3 95 70 26 23 0 0 OMIM GWAS OMIM + GWAS PolySearch2 192 106 220 DISEASES 182 138 195 DisGeNet 210 139 231 DigSee 283 198 292 ( A ) ( B ) ( C ) Distribution of coverage of disease - related genes Number of diseases having confidence overlap ( p - value ‚â§ 0 . 05 ) DigSee OMIM 569 , 115 14 , 056 3065 GWAS 424 73 3694 8463 PolySearch2 OMIM 8218 981 16 , 140 GWAS 80 417 243 11 , 914 DISEASES OMIM 165 , 445 6295 10 , 826 GWAS 261 236 2192 9965 DisGeNet OMIM 69 , 935 3051 14 , 070 GWAS 172 325 1588 10 , 569 Supplementary Figure 2 Separation coefficients calculation with top 100 genes Coefficient # of abstracts # of evidence sentences Score of evidence sentences Higher 5000 pairs Lower 5000 pairs ( A ) - 1 a 1 0 1 Separation D i s ea s e p a i r s 1500 1000 500 0 - 1 a 1 0 1 Separation D i s ea s e p a i r s 1500 1000 500 0 - 1 a 1 0 1 Separation D i s ea s e p a i r s 1500 1000 500 0 - 1 a 1 0 1 Separation D i s ea s e p a i r s 1500 1000 500 0 - 1 a 1 0 1 Separation D i s ea s e p a i r s 2000 1500 1000 500 0 - 1 a 1 0 1 Separation D i s ea s e p a i r s 2000 1500 1000 500 0 Supplementary Figure 3 Coefficient Top 100 genes Top 200 genes Top 300 genes Higher 5000 pairs Lower 5000 pairs Separation coefficients calculation ( Ranked by evidence sentences ) ( B ) - 1 a 1 0 1 Separation D i s ea s e p a i r s 1500 1000 500 0 - 1 a 1 0 1 Separation D i s e a s e p a i r s 1500 1000 500 0 - 1 a 1 0 1 Separation D i s ea s e p a i r s 2000 1500 1000 500 0 - 1 a 1 0 1 Separation D i s e a s e p a i r s 2000 1500 1000 500 0 - 1 a 1 0 1 Separation D i s ea s e p a i r s 2000 1500 1000 500 0 - 1 a 1 0 1 Separation D i s ea s e p a i r s 2000 1500 1000 500 0 GO term similarity : Biological process # of abstracts # of evidence sentences Score of evidence sentences Top 100 genes Top 200 genes Top 300 genes ( C ) GO t e r m s i m il a r it y 0 . 04 0 . 03 0 . 02 0 . 01 0 - 1 . 5 - 1 - 0 . 5 0 0 . 5 Separation GO t e r m s i m il a r it y 0 . 04 0 . 03 0 . 02 0 . 01 0 - 1 . 5 - 1 - 0 . 5 0 0 . 5 Separation GO t e r m s i m il a r it y 0 . 02 0 . 01 0 - 1 . 5 - 1 - 0 . 5 0 0 . 5 Separation GO t e r m s i m il a r it y 0 . 02 0 . 01 0 - 1 . 5 - 1 - 0 . 5 0 0 . 5 Separation GO t e r m s i m il a r it y 0 . 02 0 . 01 0 - 1 . 5 - 1 - 0 . 5 0 0 . 5 Separation GO t e r m s i m il a r it y 0 . 02 0 . 01 0 - 1 . 5 - 1 - 0 . 5 0 0 . 5 Separation GO t e r m s i m il a r it y 0 . 04 0 . 03 0 . 02 0 . 01 0 - 1 . 5 - 1 - 0 . 5 0 0 . 5 Separation GO t e r m s i m il a r it y 0 . 02 0 . 01 0 - 1 . 5 - 1 - 0 . 5 0 0 . 5 Separation GO t e r m s i m il a r it y 0 . 02 0 . 01 0 - 1 . 5 - 1 - 0 . 5 0 0 . 5 Separation GO term similarity : Cellular component # of abstracts # of evidence sentences Score of evidence sentences Top 100 genes Top 200 genes Top 300 genes ( D ) GO t e r m s i m il a r it y 0 . 006 0 . 004 0 . 002 - 1 . 5 - 1 - 0 . 5 0 0 . 5 Separation GO t e r m s i m il a r it y 0 . 006 0 . 004 0 . 002 - 1 . 5 - 1 - 0 . 5 0 0 . 5 Separation G O t e r m s i m il a r it y 0 . 004 0 . 003 0 . 002 0 . 001 - 1 . 5 - 1 - 0 . 5 0 0 . 5 Separation GO t e r m s i m il a r it y 0 . 003 0 . 002 0 . 001 - 1 . 5 - 1 - 0 . 5 0 0 . 5 Separation GO t e r m s i m il a r it y 0 . 004 0 . 003 0 . 002 0 . 001 - 1 . 5 - 1 - 0 . 5 0 0 . 5 Separation GO t e r m s i m il a r it y 0 . 003 0 . 002 0 . 001 - 1 . 5 - 1 - 0 . 5 0 0 . 5 Separation GO t e r m s i m il a r it y 0 . 006 0 . 004 0 . 002 - 1 . 5 - 1 - 0 . 5 0 0 . 5 Separation GO t e r m s i m il a r it y 0 . 003 0 . 002 0 . 001 - 1 . 5 - 1 - 0 . 5 0 0 . 5 Separation GO t e r m s i m il a r it y 0 . 003 0 . 002 0 . 001 - 1 . 5 - 1 - 0 . 5 0 0 . 5 Separation GO term similarity : Molecular function # of abstracts # of evidence sentences Score of evidence sentences Top 100 genes Top 200 genes Top 300 genes ( E ) GO t e r m s i m il a r it y 0 . 010 0 . 005 0 - 1 . 5 - 1 - 0 . 5 0 0 . 5 Separation GO t e r m s i m il a r i t y 0 . 010 0 . 005 0 - 1 . 5 - 1 - 0 . 5 0 0 . 5 Separation GO t e r m s i m il a r it y 0 . 009 0 . 006 0 . 003 0 - 1 . 5 - 1 - 0 . 5 0 0 . 5 Separation GO t e r m s i m il a r it y 0 . 009 0 . 006 0 . 003 0 - 1 . 5 - 1 - 0 . 5 0 0 . 5 Separation GO t e r m s i m il a r it y 0 . 009 0 . 006 0 . 003 0 - 1 . 5 - 1 - 0 . 5 0 0 . 5 Separation GO t e r m s i m il a r it y 0 . 009 0 . 006 0 . 003 0 - 1 . 5 - 1 - 0 . 5 0 0 . 5 Separation GO t e r m s i m il a r it y 0 . 009 0 . 006 0 . 003 0 - 1 . 5 - 1 - 0 . 5 0 0 . 5 Separation GO t e r m s i m il a r it y 0 . 010 0 . 005 0 - 1 . 5 - 1 - 0 . 5 0 0 . 5 Separation GO t e r m s i m il a r it y 0 . 009 0 . 006 0 . 003 0 - 1 . 5 - 1 - 0 . 5 0 0 . 5 Separation